PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
07-Feb-2024 Global Healthcare Regulatory Affairs Outsourcing Industry is poised to experience an 11.3% CAGR by 2033, as forecasted by Future Market Insights MARKITWIRED
07-Feb-2024 Global Anti-Osteoporosis Therapy and Fracture Healing Industry is poised to be valued at US$ 22,427.6 Million by 2033 | FMI MARKITWIRED
07-Feb-2024 Global Medication Management System Industry is expected to achieve a valuation of US$ 9.0 Billion by 2033, with substantial growth fueling its expansion, as suggested by FMI MARKITWIRED
07-Feb-2024 Global Hepatitis B Diagnostic Tests Industry is forecasted to grow at a 6.5% CAGR, reaching US$ 1,744.26 Million by 2033 | FMI MARKITWIRED
07-Feb-2024 Myotonic Dystrophy Treatment Market Sets Stage for 12.3% CAGR Growth on the Horizon by 2033 MARKITWIRED
07-Feb-2024 Myelofibrosis (MF) Treatment Market Envisions Notable US$ 1,280 Million Milestone by 2033 MARKITWIRED
07-Feb-2024 Joint Replacement Market Forges Path to Seamless Mobility, Anticipating US$ 27 Billion Valuation by 2032 MARKITWIRED
07-Feb-2024 Spine Pain Market Ramps Up for Notable US$ 12.47 Billion Valuation by 2033 MARKITWIRED
07-Feb-2024 Cystic Fibrosis Therapeutics Market Targets Remarkable US$ 116.42 Billion Valuation by 2033 MARKITWIRED
07-Feb-2024 PD1 Resistant Head and Neck Cancer Market Eyes Striking US$ 5 Billion Horizon by 2033 MARKITWIRED
07-Feb-2024 Hyperphosphatemia Market Accelerates Towards US$ 20.24 Billion with a 4.8% CAGR Through 2033 | Report By Future Market Insights MARKITWIRED
07-Feb-2024 TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO Businesswire
07-Feb-2024 CD Formulation Shows the Ability of Coated Microneedle Preparation Technology for Novel Drug Delivery CD Formulation
07-Feb-2024 CdS/ZnS Quantum Dots Are Now Available at Alfa Chemistry Alfa Chemistry
07-Feb-2024 Model N Announces First Quarter Fiscal Year 2024 Financial Results Businesswire
07-Feb-2024 Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Update Businesswire
07-Feb-2024 Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results Businesswire
06-Feb-2024 Avant Brands Announces Changes to Finance Leadership Team AccessWire
06-Feb-2024 Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split) AccessWire
06-Feb-2024 Valerio Therapeutics Announces a Capital Reduction Motivated by Losses by Reducing the Nominal Value of the Company's Shares Businesswire